Challenges in REMS compliance
Am J Health Syst Pharm
.
2021 Jun 7;78(12):1036-1037.
doi: 10.1093/ajhp/zxab075.
Authors
Archita A Pemmaraju
1
,
Craig A Stevens
1
,
Nancy T Yam
1
,
Charles E Daniels
1
Affiliation
1
University of California San Diego San Diego, CA, USA.
PMID:
33611346
DOI:
10.1093/ajhp/zxab075
No abstract available
Keywords:
FDA; REMS; adverse drug effects; hospital practice; medication safety.
Publication types
Letter
MeSH terms
Humans
Risk Assessment
Risk Management*
United States
United States Food and Drug Administration